CrossBridge Bio, a pioneering biotechnology firm dedicated to revolutionizing cancer treatment, has successfully raised $10 million in its latest funding round. Renowned for its proprietary stable dual-linker payload technology, CrossBridge Bio is at the forefront of developing innovative antibody-drug conjugates (ADCs) that offer targeted therapeutic solutions for patients battling various forms of cancer. This significant investment will enable the company to accelerate its research and development efforts, further advancing its promising ADC pipeline aimed at enhancing the efficacy and safety profile of cancer treatments. The funds will support ongoing preclinical studies and clinical trials, allowing CrossBridge Bio to rigorously test its novel therapeutics in diverse patient populations and improve treatment outcomes. Additionally, this financing will facilitate the expansion of the company鈥檚 scientific team and key collaborations with leading research institutions, reinforcing its commitment to harnessing the full potential of ADC technology. As the oncology landscape continues to evolve, CrossBridge Bio stands poised to make a substantial impact, striving to provide more effective treatments and better quality of life for cancer patients globally. The successful funding round is a testament to the confidence investors have in the company鈥檚 mission-driven approach and innovative solutions, setting the stage for an exciting future in biopharmaceutical development.
CrossBridge Bio Secures $10 Million in Seed Funding to Advance ADC Therapeutics Innovation
Recently funded 路 $10.0M SeedBiotechnology
Get the full CrossBridge Bio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  DIMENSION United States | Seed | $1.6M | today |
| 2 |  Dimension Studios United States | Seed | $1.6M | today |
